Altamira Therapeutics Stock Cash And Equivalents
Altamira Therapeutics fundamentals help investors to digest information that contributes to Altamira Therapeutics' financial success or failures. It also enables traders to predict the movement of Altamira Stock. The fundamental analysis module provides a way to measure Altamira Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Altamira Therapeutics stock.
Altamira |
Altamira Therapeutics Company Cash And Equivalents Analysis
Altamira Therapeutics' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Altamira Therapeutics Cash And Equivalents | 984.19 K |
Most of Altamira Therapeutics' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Altamira Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Altamira Therapeutics has 984.19 K in Cash And Equivalents. This is 99.88% lower than that of the Biotechnology sector and 99.78% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.96% higher than that of the company.
Altamira Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Altamira Therapeutics' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Altamira Therapeutics could also be used in its relative valuation, which is a method of valuing Altamira Therapeutics by comparing valuation metrics of similar companies.Altamira Therapeutics is currently under evaluation in cash and equivalents category among its peers.
Altamira Fundamentals
| Return On Equity | -3.69 | |||
| Return On Asset | -0.57 | |||
| Current Valuation | 860.75 K | |||
| Shares Outstanding | 3.78 M | |||
| Shares Owned By Insiders | 0.52 % | |||
| Shares Owned By Institutions | 3.13 % | |||
| Number Of Shares Shorted | 50.63 K | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 0.64 X | |||
| Gross Profit | (2.18 M) | |||
| EBITDA | (1.35 M) | |||
| Net Income | (3.87 M) | |||
| Cash And Equivalents | 984.19 K | |||
| Cash Per Share | 1.29 X | |||
| Total Debt | 99.66 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 2.37 X | |||
| Cash Flow From Operations | (11.51 M) | |||
| Short Ratio | 0.52 X | |||
| Earnings Per Share | 1.82 X | |||
| Target Price | 4.92 | |||
| Number Of Employees | 10 | |||
| Beta | 2.44 | |||
| Market Capitalization | 1.13 M | |||
| Total Asset | 7.69 M | |||
| Retained Earnings | (18.05 M) | |||
| Working Capital | 334.24 K | |||
| Net Asset | 7.69 M |
Pair Trading with Altamira Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altamira Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Oracle could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oracle when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oracle - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oracle to buy it.
The correlation of Oracle is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oracle moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oracle moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oracle can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |